Preventive Effects of Probiotic Supplementation on Neonatal Hyperbilirubinemia Caused by Isoimmunization

Abstract

Objective Probiotic supplementation can help to improve recovery from jaundice by reducing enterohepatic circulation through the regulation of intestinal microbial flora. The aim of our study was to investigate the effect of probiotic supplementation on neonatal hyperbilirubinemia caused by isoimmunization alone.

Study Design Sixty neonates were randomly divided into a placebo group and a probiotic group (Lactobacillus rhamnosus GG). Serum total bilirubin (STB) levels were measured at birth and at 4, 8, 16, 24, and 36 hours of treatment (and at 48, 60, and 72 hours if necessary). Duration of phototherapy, rephototherapy requirements, and daily meconium evacuation were recorded.

Results STB and rebound STB levels at 36 hours were lower in the probiotic group than in the placebo group (p = 0.01 and p = 0.006, respectively). Meconium evacuation was more frequent in the probiotic group than in the placebo group on the second and third days of life (p = 0.002 and 0.009, respectively).

Conclusion Probiotics do not affect STB levels in the first 24 hours of life or duration of phototherapy in neonates with jaundice caused by blood group incompatibility. The effect of probiotic supplementation by reducing enterohepatic circulation occurs at 36 hours of life in newborns with isoimmunization.

Keywords

jaundice - probiotic - isoimmunization - meconium

Publication History

Received: 16 April 2019

Accepted: 14 May 2019

Article published online:
26 June 2019

• References

• 1 Kaplan M, Wong RJ, Sibley E, Stevenson DK. Neonatal jaundice and liver diseases. In: Martin RJ, Fanaroff AA, Walsh MC. , eds. Fanaroff and Martin's Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. 9th ed. Maryland Heights, MO: Elsevier Mosby; 2011: 1443-1496
• 2 Kaplan M, Merlob P, Regev R. Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol 2008; 28 (06) 389-397
• 3 National Collaborating Centre for Women's and Children's Health. Neonatal Jaundice. London: NICE; 2010
• 4 American Academy of Pediatrics, Clinical Practice Guideline, Subcommittee on Hyperbilirubinemia. Management of the newborn 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316
• 5 Rennie J, Burman-Roy S, Murphy MS. Guideline Development Group. Neonatal jaundice: summary of NICE guidance. BMJ 2010; 340: c2409
• 6 Piazza AJ, Stoll BJ. Digestive system disorders. In: Kliegman RM, Behrman RE, Jenson HB, Stanton B. , eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: Saunders Elsevier; 2007: 756-771
• 7 Tiribelli C, Ostrow JD. Intestinal flora and bilirubin. J Hepatol 2005; 42 (02) 170-172
• 8 Chen Z, Zhang L, Zeng L. , et al. Probiotics supplementation therapy for pathological neonatal jaundice: a systematic review and meta-analysis. Front Pharmacol 2017; 8: 432
• 9 Pasha YZ, Ahmadpour-Kacho M, Jazi AA, Gholinia H. Effect of probiotics on serum bilirubin level in term neonates with jaundice: a randomized clinical trial. Int J Pediatr 2017; 5 (10) 5925-5930
• 10 Serce O, Gursoy T, Ovali F, Karatekin G. Effects of Saccharomyces boulardii on neonatal hyperbilirubinemia: a randomized controlled trial. Am J Perinatol 2015; 30 (02) 137-142
• 11 Deshmukh J, Deshmukh M, Patole S. Probiotics for the management of neonatal hyperbilirubinemia: a systematic review of randomized controlled trials. J Matern Fetal Neonatal Med 2019; 32 (01) 154-163